Loading clinical trials...
Loading clinical trials...
The objective of this study is to assess the bioavailability of risankizumab liquid vial manufactured with the new process (CMC3) relative to the current process (CMC2).
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT05545306 · Obesity, Normal Physiology, and more
NCT06649110 · Healthy Volunteers, Pulmonary Arterial Hypertension
NCT00104325 · Healthy Volunteers
NCT07118891 · Vasomotor Symptoms Associated With Menopause, Healthy Volunteers
NCT01399385 · Healthy, Obesity, and more
Anaheim Clinical Trials LLC /ID# 260740
Anaheim, California
Clinical Pharmacology of Miami /ID# 260800
Miami, Florida
Acpru /Id# 260864
Grayslake, Illinois
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions